Treatment of Paecilomyces variotii pneumonia with posaconazole: case report and literature review. Mycoses 2016 Dec;59(12):746-750
Date
07/13/2016Pubmed ID
27401982DOI
10.1111/myc.12525Scopus ID
2-s2.0-84978191719 (requires institutional sign-in at Scopus site) 27 CitationsAbstract
The fungi Paecilomyces variotii is a potential pathogen in immunocompromised and immunocompetent patients. Their rare association with clinical disease results in scarce literature regarding susceptibility and treatment. Here, we discuss a case involving successful treatment of probable P. variotii pneumonia with posaconazole after treatment failure with voriconazole. The current literature related to antifungal susceptibility profiles, microbiological identification methods and clinical management of infections caused by this organism is also reviewed.
Author List
Feldman R, Cockerham L, Buchan BW, Lu Z, Huang AMAuthors
Blake W. Buchan PhD Professor in the Pathology department at Medical College of WisconsinLeslie Cockerham MD Associate Professor in the Medicine department at Medical College of Wisconsin
Ryan J. Feldman PharmD Adjunct Assistant Professor in the School of Pharmacy Administration department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Antifungal AgentsFemale
Humans
Middle Aged
Mycoses
Paecilomyces
Pneumonia
Triazoles